Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA (vol 34, pg 451, 2018)

被引：0

作者：

McKeage, Kate ^{[1
]}

Lyseng-Williamson, Katherine A. ^{[1
]}

机构：

[1] Springer, Private Bag 65901,Mairangi Bay, Auckland 0754, New Zealand

来源：

DRUGS & THERAPY PERSPECTIVES | 2018年 / 34卷 / 12期

关键词：

D O I：

10.1007/s40267-018-0575-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：594 / 594

页数：1

共 50 条

[21] Ginkgo biloba extract EGb 761® in the symptomatic treatment of mild-to-moderate dementia: a profile of its use (vol 34, pg 358, 2018)
McKeage, Kate
Lyseng-Williamson, Katherine A.
DRUGS & THERAPY PERSPECTIVES, 2019, 35 (01) : 48 - 48
[22] Use of exploratory factor analysis in maritime research (vol 34, pg 91, 2018)
Maskey, Reenu
Fei, Jiangang
Nguyen, Hong-Oanh
ASIAN JOURNAL OF SHIPPING AND LOGISTICS, 2021, 37 (02) : 209 - 209
[23] Response: Prescription Opioid Use and the Risk of Disability (vol 34, pg 190, 2018)
Franche, R-L
Carnide, N.
Lee, H.
Hogg-Johnson, S.
CLINICAL JOURNAL OF PAIN, 2018, 34 (05) : 485 - 485
[24] Subacute sclerosing panencephalitis and immune thrombocytopenia: More than a coincidence? (vol 111, pg 70, 2018)
Oncel, Ibrahim
Saltik, Sema
Anlar, Banu
MEDICAL HYPOTHESES, 2020, 138
[25] Ivosidenib in relapsed or refractory acute myeloid leukemia: a profile of its use in the USA (vol 35, pg 160, 2019)
McCafferty, Emma H.
Lyseng-Williamson, Katherine Ann
DRUGS & THERAPY PERSPECTIVES, 2019, 35 (09) : 460 - 460
[26] EltrombopagA Review of its Use in Treatment-Refractory Chronic Primary Immune Thrombocytopenia
Karly P. Garnock-Jones
Drugs, 2011, 71 : 1333 - 1353
[27] Difelikefalin in pruritus associated with chronic kidney disease: a profile of its use (vol 38, pg 423, 2022)
Lamb, Yvette N.
DRUGS & THERAPY PERSPECTIVES, 2022, 38 (11) : 500 - 500
[28] Eltrombopag A Review of its Use in Treatment-Refractory Chronic Primary Immune Thrombocytopenia
Garnock-Jones, Karly P.
DRUGS, 2011, 71 (10) : 1333 - 1353
[29] Estimation of riluzole levels in human milk and infant exposure during its use in a patient with ALS (vol 34, pg 355, 2018)
Datta, P.
Rewers-Felkins, K.
Aurora, N.
Baker, T.
Hale, T. W.
JOURNAL OF HUMAN LACTATION, 2019, 35 (03) : 632 - 632
[30] Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20 mg/5 mg/12.5 mg fixed-dose combination in hypertension: a profile of its use (vol 34, pg 1, 2018)
Lyseng-Williamson, Katherine A.
DRUGS & THERAPY PERSPECTIVES, 2018, 34 (07)

← 1 2 3 4 5 →